Not registered yet? Please contact our project manager Dr. Sara Stöber . This area is only for members of the research consortium.

News

30 July 2021

French translation of QSPainRelief info brochure ready for the WP8 clinical trial

You can now access a web and a print version of the project’s info brochure translated into French on the DOWNLOADS or TÉLÉCHARGEMENTS page, respectively. Thanks a bunch for the help of the team at UCL in providing the translations. We hope the brochure will be well-received by pain patients participating in the clinical trial of WP8, which is starting soon!

More news

Events

4-6 November 2021

Register now: EFIC Virtual Pain Education Summit

The biggest online pain education event of the year will take place from 4-6 November 2021. With a dedicated track for physicians based on the EFIC Pain Curricula for Pain Medicine as well as topical lectures and interprofessional sessions, the #EFICVirtualPainSummit 2021 is your chance to advance your knowledge in pain management and learn from leading experts in their field!

More events
Personalise and maximize pain relief for individuals suffering from chronic pain

Summary Statement

10 institutions in Europe and the USA collaborate for the next 5 years to help patients suffering from chronic pain. QSPainRelief aims to develop effective drug combination treatments for the improved relief of chronic pain. A quantitative systems pharmacology (QSP) mathematical modelling approach will be used to identify and validate more effective therapeutic interventions by smart combinations of existing drugs. The ultimate goal is to personalise and maximize pain relief for individuals suffering from chronic pain while diminishing side effects.

Learn more

Objectives

  • Consolidating cutting-edge treatment models for chronic pain
  • Summary Statement
  • Validating novel combinational therapies preclinically in vitro and in vivo
  • Conducting clinical studies to detect functional biomarkers
  • Improving the clinical guidelines for pain relief in stratified patient groups
  • Personalising pain relief treatment for each patient
  • Improving the scientific understanding of chronic pain regarding age, sex, disease and genetic factors

Impact

  • Novel concepts of combinational pain relief therapies
  • Improved efficacy and acceptability in the clinic
  • Effective stratification of patients with respect to age, sex, disease and genotype
  • Personalised treatment with unswerving benefits for patients
  • Unique knowledge gain and innovation opportunities